van Dijk K N, van Asselt D Z B, Vogel D, van der Hooft C S, Van Roon E N, Brouwers J R B J
Medisch Centrum Leeuwarden, afdeling Klinische Farmacologie.
Tijdschr Gerontol Geriatr. 2009 Apr;40(2):72-8.
To study the results of a structured medication review of geriatric inpatients by both geriatrician and hospital pharmacist/clinical pharmacologist.
Patients who were present at the geriatric ward were eligible for a review of their medication and medical problems using a screening form. Recommendations and questions following these forms were subsequently discussed in the gerontopharmacologic meeting ('GFO') held every two weeks.
In a 30 month-period 44 GFO's were held during which 184 patients were discussed. A total of 206 recommendations were made and 115 questions were asked. Of the recommended interventions,134 (65%) were accepted by the geriatrician. To stop a medication (64/206), to change the dosage of a medication (60/206) and to switch to another medication (44/206) were the types of interventions most accounted for.
Structured medication review led to a substantial number of medication changes in geriatric inpatients. Nearly two-thirds of the recommended interventions were accepted by the geriatricians. Seventy-two recommendations (35%) were not implemented due to logistic or patient-related reasons.
研究老年科医生与医院药剂师/临床药理学家对老年住院患者进行结构化药物审查的结果。
入住老年病房的患者有资格使用筛查表对其用药和医疗问题进行审查。随后,在每两周举行一次的老年药理学会议(“GFO”)上讨论根据这些表格提出的建议和问题。
在30个月的时间里,共举行了44次GFO会议,期间讨论了184名患者。总共提出了206条建议,询问了115个问题。在建议的干预措施中,134条(65%)被老年科医生接受。最常见的干预措施类型是停用一种药物(64/206)、改变一种药物的剂量(60/206)和换用另一种药物(44/206)。
结构化药物审查导致老年住院患者的大量用药改变。近三分之二的建议干预措施被老年科医生接受。72条建议(35%)由于后勤或患者相关原因未得到实施。